Subpoena scuffle puts American Senior Communities fraud case on contentious course
Prosecutors argue that subpoenas issued by counsel for the nursing home company's former CEO are overly broad and "an abuse of process."
Health Care & Life Sciences
Articles
Lilly CFO Derica Rice to leave company in December
Rice, 52, who had been the company's top finance officer since 2006, is one of the most powerful black executives in corporate America. He had been widely considered a leading candidate to succeed CEO John Lechleiter, but that position went to fellow Lilly executive Dave Ricks.
Drugmakers brace for Trump proposals to tackle U.S. prices
Top pharmaceutical CEOs say they expect President Donald Trump, a frequent critic of industry pricing practices, to take steps soon to address high U.S. drug costs.
Women’s Fund involves nine area communities in new mental health initiative
For the first time since its founding in 1996, the Women’s Fund of Central Indiana is supporting an initiative that’s not exclusive to females.
Danville firm grows as other states embrace controversial chemical cremation method
Bio-Response Solution’s flagship product liquefies human corpses, turning muscle, flesh and fat into a coffee-colored effluent that can be swirled down the drain.
FIDDIAN-GREEN & KLOTH: Training more addiction specialists will have life-saving consequences
Indiana ranks 44th nationwide in the capacity to meet the medication-assisted treatment needs of our population.
Brown calls genomics startup ‘riskiest thing I’ve ever done’
LifeOmic is seeking to help doctors provide more precise treatments for patients by sequencing their DNA.
Insurers continue to hike prices, abandon Obamacare markets
People shopping for insurance through the Affordable Care Act in yet more regions could be facing higher prices and fewer choices next year. A new report shows Affordable Care Act premiums have soared since 2013.
Roche hoping to gain edge with new diabetes-testing product
Roche Group is rolling out a new blood-glucose meter and a savings program for test strips, which it says it will make diabetes care more affordable.
Lilly Endowment assets ebb in 2016 as it grants $452.8M
After several years in which the value of its assets swelled, philanthropic giant Lilly Endowment Inc. watched its coffers shrink 12.7 percent in 2016 from about $11.8 billion to $10.3 billion.
Former IU Health CEO to join law firm’s consulting arm
Dan Evans, who for 13 years was president and CEO of Indiana University Health, has joined Faegre Baker Daniels Consulting as a senior director in its health and biosciences group.
Lilly hires ‘powerhouse’ D.C. lobbyist
Leigh Ann Pusey will join Eli Lilly and Co. next month as senior vice president for corporate affairs and communications.
Planned Parenthood challenging new Indiana abortion parental consent law
Planned Parenthood of Indiana and Kentucky has filed a lawsuit challenging portions of Senate Enrolled Act 404, which in part requires unemancipated minors to obtain consent from a parent or legal guardian before having an abortion.
OurHealth raises $37M, plans to hire 480 workers
The privately held company operates 32 clinics for employers in Indianapolis, Chicago, Nashville and other cities. The new funds will allow it to expand and invest in data, marketing and business development.
Progress on reducing U.S. uninsured rate comes to halt
Five years of progress reducing the number of Americans without health insurance has come to a halt. It will be watched closely as Republicans attempt to roll back the Affordable Care Act.
Jury acquits Indianapolis doctor charged in patients’ deaths
A jury acquitted Dr. John K. Sturman of reckless homicide and 16 counts of improperly prescribing drugs on Monday following a six-day trial.
Anthem abandons battle for Cigna after court deals blow to deal
Anthem says it is giving up on the $48 billion purchase in the wake of a Thursday court ruling giving Cigna the right to walk away. The Indianapolis-based insurer says Cigna is not entitled to collect a $1.85 billion breakup fee.
Lilly migraine drug provides relief in late-stage trials
Lilly is in a race with several pharmaceutical firms to develop migraine treatments using an approach known as anti-CGRP and that could create a multibillion-dollar market.
Doctor suspended over sex with patient unhappy with licensing board’s minutes
Dr. John Steenbergen admitted he had a sexual relationship with a patient for five years and performed an abortion on her, but said the licensing board unfairly characterized the matter.
Insurer Aetna decides to completely leave Obamacare markets
Aetna has said it expects to lose more than $200 million on individual health plans this year in the four states where it’s still selling Affordable Care Act plans.